About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials | 694 Studies Recruiting

Clinical TrialsPsoriasis

Psoriasis Clinical Trials

Browse 694 clinical trials for psoriasis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 681-694 of 694 trials

CompletedAn Ascending Multiple Dose Study With VTP-43742 in Healthy VolunteersThis is Part 1 of a two-part, randomized, double-blind, placebo-controlled study in which VTP-43742 was administered to participants; Part 1 in healthy volunteers and Part 2 in…NCT03724292·Fair Lawn, New Jersey CompletedComparison of Secukinumab Versus Guselkumab in Clearing Psoriatic Plaques Refractory to UstekinumabThe aim of this study was to describe the effect of direct IL-17A inhibition with secukinumab as compared with the selective inhibition of IL-23 with guselkumab (p19 subunit…NCT03553823·New Orleans, Louisiana and 13 others RecruitingImaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic ArthritisThe main objective is to assess if a treat-to-target strategy implementing structured imaging assessments leads to better patient outcome in terms of sustained remission compared…NCT05291819·Ålesund and 11 others

Related Searches

psoriatictrials

Data from ClinicalTrials.govTerms

CompletedEvaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisThis is a study to demonstrate the clinical efficacy and safety of the nanobody® sonelokimab administered subcutaneously (sc) compared with placebo in the treatment of adult…NCT05640245·Rancho Mirage, California and 41 others

TerminatedA Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197A Phase 2, Multicenter, Open-Label Extension (OLE) Study with ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 Phase 2 Randomized…NCT02429895·Woolloongabba and 35 others

CompletedOne-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort StudyA study to describe the one-year persistence in participants treated by Flixabi (infliximab) or Imraldi (Adalimumab) as prescribed by the physician for each of the 5 following…NCT03662919·Caluire-et-Cuire, Auvergne-Rhône-Alpes and 59 others

CompletedA Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic ArthritisThis study is aim to evaluate the efficacy and safety of technetium \[99Tc\] methylene diphosphonate (99Tc-MDP, trade name: Yunke) in the treatment of psoriatic arthritis.NCT05000086·Beijing, Dongcheng

RecruitingOxidative Stress in Autoimmune Rheumatic DiseasesRheumatic diseases constitute a group of non-communicable diseases characterized by chronic inflammation.NCT07536529·Larissa, Thessaly

Not yet recruitingA Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic ArthritisThe goal of this observational study is to evaluate how well advanced therapies work in adults with psoriatic arthritis (PsA) who are starting a biologic or targeted synthetic…NCT07417995·Bath

CompletedA Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisThis is a study to demonstrate the clinical efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared with placebo in the treatment of subjects…NCT03895203·Phoenix, Arizona and 135 others

UnknownEfficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and InsufficiencyThe purpose of this research is to study whether vitamin D supplement can improve clinical outcome (PASI score) in psoriasis vulgaris with vitamin D insufficiency and deficiency.NCT01339741·Patumwan, Bangkok

CompletedA Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in IndiaThe main purpose of this study is to investigate the safety and tolerability of ixekizumab in participants in India with moderate-to-severe plaque psoriasis (PsO) or active…NCT05855967·Vizag, Andhra Pradesh and 13 others

UnknownResponse to Upadacitinib of Enthesitis Evaluated by Ultrasound in Patients With Psoriatic ArthritisPrimary objective To evaluate the peripheral enthesitis response to upadacitinib treatment by BMUS and DMUS, in PsA patients at week 24. Secondary objective: 1.NCT06144567·Madrid

CompletedA Study of RO5310074 in Patients With Psoriatic ArthritisThis randomized, double-blind. placebo-controlled study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple doses of RO5310074 in patients with…NCT01199809·Anniston, Alabama and 8 others

PreviousPage 35 of 35